Assessing quality of life in the treatment of patients with age-related macular degeneration: clinical research findings and recommendations for clinical practice
Author(s) -
Mitsuko Yuzawa,
Fujita,
Erika Tanaka,
Wang
Publication year - 2013
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s45248
Subject(s) - medicine , macular degeneration , quality of life (healthcare) , disease , clinical practice , depression (economics) , population , visual acuity , gerontology , physical therapy , ophthalmology , nursing , macroeconomics , environmental health , economics
The importance of incorporating quality-of-life (QoL) assessments into medical practice is growing as health care practice shifts from a "disease-based" to a "patient-centered" model. The prevalence of age-related macular degeneration (AMD) is increasing in today's aging population. The purpose of this paper is: (1) to discuss, by reviewing the current literature, the impact of AMD on patients' QoL and the utility of QoL assessments in evaluating the impact of AMD and its treatment; and (2) to make a recommendation for incorporating QoL into clinical practice.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom